title: Mithramycin targets sp1 and the androgen receptor transcription level-potential therapeutic role in advanced prostate cancer.
abstract: Multiple lines of evidence implicate over-expression and activation of the androgen receptor (AR) in the progression of prostate cancer (PC) to androgen-independence (AI) and resistance to therapy. The mechanisms leading to AR over-expression are not fully understood but binding of Sp1 to specific Sp1-binding sites in the AR promoter and 5'-untranslated region (5'-UTR) was shown to up-regulate AR transcription. In this work, we further characterized the role of Sp1 in the control of AR transcription and explored its potential as a therapeutic target in androgen-dependent (AD) and independent (AI) LNCaP cells. We identified a pair of new Sp1-binding site in the 5'-UTR of AR which we named ARSp1-3. ARSp1-3 binds Sp1 with higher affinity than other known Sp1-binding sites in the promoter/5'-UTR and in transfection experiments, the ARSp1-3 reporter showed higher transcriptional activity in AI than in AD cells. Treatment of these cells with nanomolar concentrations of Mithramycin inhibited binding of Sp1 to its binding sites in the promoter/5'-UTR of the AR gene but more specifically the binding of ARSp1-3 while other regulatory elements of the AR promoter were not affected. Inhibition of Sp1 binding by Mithramycin decreased the AR transcription and transactivation of PSA reporter constructs. At the lowest concentrations, Mithramycin decreased endogenous AR protein and proliferation of AD and AI LNCaP cells. The combinations of Mithramycin with either paclitaxel or bicalutamide were highly synergistic.
  
  
  CONCLUSIONS
  Sp1 binding induces AR transcription in LNCaP cells. The higher affinity of ARSp1-3 for Sp1 may support higher AR mRNA levels in AI than AD LNCaP cells. Mithramycin is a potent and specific inhibitor of Sp1 and AR transcription with potential, at very low concentrations, to enhance the efficacy of hormones or taxane based therapy in patients with recurrent or androgen-independent progression that sustain AR expression.
authors: NYU Cancer Institute, Department of Medicine, New York University School of Medicine 423 East, 23rd New York, NY 10010.
authors: Long G
authors: LG
authors: Wang
authors: Anna C
authors: AC
authors: Ferrari
keywords: Mithramycin; Sp1; androgen receptor; chemo-hormonal therapy; prostate cancer
references: Mol Endocrinol. 1999 Sep;13(9):1487-96
references: 10478840
references: Nature. 1999 Feb 4;397(6718):446-50
references: 9989412
references: Cancer Res. 1990 Sep 1;50(17):5382-6
references: 2386943
references: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7379-84
references: 9636157
references: Mol Cell Endocrinol. 1996 May 17;119(1):83-93
references: 8793857
references: Cancer Res. 1999 Jan 15;59(2):279-84
references: 9927031
references: J Biol Chem. 1995 Jan 13;270(2):837-42
references: 7822319
references: Cancer Gene Ther. 2000 Jul;7(7):997-1007
references: 10917202
references: J Biol Chem. 1997 Aug 29;272(35):22199-206
references: 9268365
references: Mol Endocrinol. 1996 Oct;10(10):1167-77
references: 9121485
references: Cancer Cell Int. 2005 Apr 06;5(1):8
references: 15813967
references: Oncogene. 2004 Jul 1;23(30):5175-84
references: 15156193
references: J Biol Chem. 1990 Aug 15;265(23):13776-81
references: 2380187
references: Br J Cancer. 2003 Oct 20;89(8):1566-73
references: 14562033
references: Cancer Res. 1997 Jan 15;57(2):314-9
references: 9000575
references: Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6319-23
references: 1631125
references: Am J Pathol. 1995 Dec;147(6):1608-14
references: 7495286
references: J Urol. 2001 Oct;166(4):1514-9
references: 11547123
references: Nat Genet. 1995 Apr;9(4):401-6
references: 7795646
references: J Biol Chem. 1994 Oct 14;269(41):25655-9
references: 7929269
references: Cell Growth Differ. 1994 Nov;5(11):1243-51
references: 7848925
references: Adv Cancer Res. 1996;68:225-55
references: 8712069
references: Cancer Res. 2000 Dec 15;60(24):6841-5
references: 11156376
references: J Cell Biochem. 2005 Jul 1;95(4):657-69
references: 15861399
references: Nat Med. 2004 Jan;10(1):33-9
references: 14702632
references: J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25
references: 11106683
references: J Biol Chem. 2003 May 9;278(19):17557-65
references: 12609999
references: Cancer. 2001 Jun 1;91(11):2039-45
references: 11391583
references: Cancer Res. 2002 Feb 15;62(4):1008-13
references: 11861374
references: Cancer Res. 1998 Oct 15;58(20):4640-5
references: 9788616
references: Mol Cell Endocrinol. 1990 Jan 22;68(2-3):C7-10
references: 2178998
references: Acta Chir Belg. 1971 Apr;70(4):393-400
references: 4111137
references: Biochem Biophys Res Commun. 2001 Apr 27;283(1):179-87
references: 11322786
references: Am J Pathol. 2006 Aug;169(2):682-96
references: 16877366
references: Cancer Res. 1990 Apr 15;50(8):2275-82
references: 2317815
references: Cancer Res. 2004 Jan 15;64(2):743-50
references: 14744793
references: Cancer Res. 1999 Nov 1;59(21):5483-7
references: 10554023
references: Cell. 1990 Oct 5;63(1):155-65
references: 2170018
references: J Biol Chem. 2002 Apr 5;277(14):11904-9
references: 11809758
references: Cancer Res. 1994 Jun 1;54(11):2861-4
references: 8187068
references: Biochem Biophys Res Commun. 2001 Jan 12;280(1):68-74
references: 11162479
references: Cancer Res. 1998 Dec 15;58(24):5718-24
references: 9865729
references: Biochem J. 1991 Aug 15;278 ( Pt 1):269-78
references: 1883336
references: Oncogene. 2000 Apr 6;19(15):1924-32
references: 10773882
references: Science. 1997 Aug 15;277(5328):965-8
references: 9252329
references: Mol Cell Biol. 1994 Sep;14(9):6068-74
references: 8065340
references: Nat Med. 1999 Mar;5(3):280-5
references: 10086382
references: J Biol Chem. 1999 Mar 19;274(12):7777-83
references: 10075669
references: Cancer Res. 1997 Feb 15;57(4):714-9
references: 9044850
references: Cancer Res. 2001 May 1;61(9):3550-5
references: 11325816
references: Biochem Biophys Res Commun. 1997 Dec 8;241(1):142-50
references: 9405248
references: J Natl Cancer Inst. 1994 Oct 19;86(20):1517-24
references: 7932806
references: Endocrinology. 1990 May;126(5):2359-68
references: 2184015
references: Cancer Res. 1981 Dec;41(12 Pt 1):5070-5
references: 7307008
references: Cancer Res. 2001 Oct 15;61(20):7544-51
references: 11606392
references: Carcinogenesis. 2005 Apr;26(4):793-801
references: 15661808
references: Mol Cell Endocrinol. 1995 Apr 28;110(1-2):R1-6
references: 7672438
references: J Cell Physiol. 1999 Jun;179(3):336-46
references: 10228952
references: J Inorg Biochem. 2003 Feb 1;94(1-2):72-7
references: 12620675
references: J Biol Chem. 1991 Jun 15;266(17):10743-9
references: 1710213
references: J Biol Chem. 1995 May 5;270(18):10968-75
references: 7738038